Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CX1-C5222 | Cynomolgus | Cynomolgus CX3CL1 / Fractalkine Protein, His Tag (MALS verified) |
|
||
CX1-H5221 | Human | Human CX3CL1 / Fractalkine Protein, His Tag |
|
||
CX1-H8221 | Human | Biotinylated Human CX3CL1 Protein, His Tag, ultra sensitivity, primary amine labeling |
|
The purity of Cynomolgus CX3CL1 Protein, His Tag (Cat. No. CX1-C5222) is more than 90% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Quetmolimab | E-6011; KANAB-001 | Phase 2 Clinical | Eisai Co Ltd | Arthritis, Rheumatoid; Cholangitis, Sclerosing; Crohn Disease | Details |
This web search service is supported by Google Inc.